On April 16, 2004, a
class action suit was filed against Eli Lilly for relief for patients who had
taken Zyprexa and subsequently suffered from diabetes or its complications. It
also sought relief for those who had or were taking Zyprexa and had no side
effects to pay for testing for diabetes and its complications. Eli Lilly said
that it had listed the risk of high blood sugar and diabetes since 1996. The
lawsuit contended that the company did not adequately warn about possible side
effects.
In June of 2005, Eli Lilly settled 75% of the lawsuits against it with a
payout of 690 million dollars. It did not admit any wrong doing on its part but
said it didn't want to get bogged down in continuous and complicated litigation.